Partner News

Author Archives: China Briefing

R&D Pharmaceutical Professionals in China Under the Microscope

Posted on by


By Direct HR

Pharmaceutical companies are expanding their manufacturing and R&D facilities in China at a rate four times greater than the forecasted investment for the United States during 2015 – 2022. This has caused a surging demand for R&D professionals in China from both local and global pharma companies and CROs that are actively hiring.

In this article, we detail the results of our analysis on China’s pharmaceutical industry, focusing on R&D professionals rather than organizations whose sole activity gravitates around medical devices. We have analyzed over 2.100 resumes from professionals at 44 companies both from China-based organizations (66.5 percent) and global pharma players (33.5 percent).

Key Take-Aways

Finding #1:

The talent pool of R&D professionals for the pharmaceutical industry in China concentrates fundamentally along the Yangtze River delta: 70.3 percent of the professionals analyzed are located there, with the key location being Shanghai (57.4 percent).

However, important differences emerge between the location strategies of local pharmaceutical companies and foreign, non-Chinese, based organizations. Whereas the former are predominantly located in Shanghai (67.4 percent), the latter mostly split their R&D operations between Shanghai (37.6 percent) and Beijing (31.5 percent).

Finding #2:

R&D talents at non-Chinese based firms have, on average, more working experience (7y 2m) than their colleagues at Chinese firms (5y 7m). This is mostly due to the fact that Chinese firms are betting more intensively on young talent (less than four years of working experience) and only 17.0 percent of the R&D functions there are held by professionals with more than eight years working experience.

Organizations looking for R&D professionals should bear in mind that, on average, they will remain for about 2y 10m before moving to another employer; for managers, this is significantly higher (about 4y 4m). 82.5 percent of the professionals analyzed remain less than four years per employer (63.6 percent for managers).

Finding #3:

Finally, Chinese firms seem to have a better grasp on the talent supply landscape for R&D professionals in China. The distribution of their job openings matches the supply better than openings coming from non-Chinese based firms.

Professional Service_CB icons_2015RELATED: Human Resource Services from Dezan Shira & Associates
At First Glance

R&D professionals are on average 32.8 years old. They are predominantly male (62.8 percent) and, as level of seniority increases, this gender unbalance becomes more acute: about 70.5 percent of managers are men. Men tend to have slightly more work experience and are generally older: 68.0 vs. 76.5 months of working experience; 32.2 years old vs. 33.2.

Pharma R&D talent has an average work experience of 73.8 months, which is roughly six years and two months, and an employment stability of 33.8 months (about 2y 9m). For managerial positions, R&D professionals have on average 117.8 months (about 9y 9m) of working experience and are 37.6 years old.

Young professionals (those with less than four years of working experience) represent 30.8 percent, whereas senior professionals (eight years and above) are 22.8 percent.

The Yangtze River delta (Shanghai, Nanjing, Suzhou) account for 70.3 percent of the professionals; the Bohai economic rim – which surrounds Beijing and Tianjin – adds up to 15.8 percent; and the Pearl River delta in the south (Guangzhou, Shenzhen) makes for 3.3 percent.

Noteworthy are the cases of Beijing and Shanghai: the latter holds the lion’s share with 57.4 percent of all R&D professionals, while Beijing follows with 14.9 percent. Behind those come Jiangsu (8.5 percent), Guangdong (3.5 percent) and Tianjin (3.1 percent).

Working Experience

Non-Chinese based players rely on more experienced staff than their local counterparts. Overall, non-Chinese R&D professionals have a total work experience of 86.2 months (about 7y 2m), in stark contrast to the 67.5 months (5y 7m) of Chinese professionals.

Young professionals represent 23.2 percent of the total R&D force in non-Chinese companies, whereas this proportion is nearly 1.5 times higher at Chinese players: 34.5 percent. The opposite is true for senior professionals: 17.1 percent in Chinese companies and double in non-Chinese ones (34.3 percent).

All things considered, there are no significant differences in overall employment stability between Chinese and non-Chinese based players. If any, the former presents slightly superior employment stability: 34.1 versus 33.2 months. Furthermore, for every level of seniority measured, Chinese organizations yield better – if just slightly – employment stability figures.

Managers are relatively less stable in non-Chinese companies – 51.8 months per employer and 71.9 percent of them moving before 4 years – but more seasoned: on average, 130.7 months of working experience and 39.9 years old. Managers at Chinese companies are younger (36.3 years old) and less experienced (110.3 months) but relatively more stable (52.8 months, with 58.9 percent remaining less than 4 years per employer).

Geographical Location of R&D Talent

Interesting differences can be observed between Chinese and non-Chinese organizations when looking at their respective talent distribution.

Non-Chinese pharma companies have a less prominent presence in the Yangtze River: 52.1 percent vs. 79.5 percent at local companies. This is due to their relatively lower presence in Shanghai, where they concentrate “only” 37.6 percent of their R&D talent, compared to the 67.4 percent of Chinese organizations.

In fact, non-Chinese pharmaceutical companies’ talent is almost as present in Beijing as in Shanghai (31.5 and 37.6 percent, respectively) while Chinese organizations’ talent is, in comparison, practically dismissing Beijing with only 6.6 percent of its R&D talent located there.

Related Link IconRELATED: R&D Pharmaceutical Professionals in China Free Report

Gender Balance

Non-Chinese organizations are more gender balanced than local ones: 44.3 percent vs. 33.7 percent women respectively. However, as working experience goes up in non-Chinese companies, the gender gap increases as well. Women are less likely to reach managerial responsibilities in the R&D area at non-Chinese organizations, with only 24.1 percent of women managers there as opposed to 32.1 percent at local companies.

Talent Supply and Talent Demand

We have compared the current location of R&D professionals with the distribution of job ads published by the same set of employers in 2014 in Chinese online job boards (307 job ads).

Shanghai, which accounts for 57.4 percent of the professionals, accumulated 38.8 percent of job ads in 2014; Beijing has 10.4 percent of opening opportunities while the pool of professionals there amounts for 14.9 percent of the total. As a result, filling up positions in Shanghai and Beijing should be relatively easier, since proportionally the distribution of supply is greater than demand. However, it’s important to highlight that our job-ads analysis doesn’t take into account job requirements or compensation details.

On the other hand, distribution of the demand is higher than supply at Jiangsu and Zhejiang provinces.  That’s especially true in Jiangsu, where supply is almost 11 percentage points (p.p.) above talent availability: 19.2 percent vs. 8.4 percent. At Zhejiang the difference is not that significant, with demand at 4.9 percent overtaking the supply (1.9 percent).

Chinese local firms, from a geographical perspective, are doing a better job in reading the talent market, with a distribution of the demand more in line with the distribution of the supply.

Educational Background of R&D Professionals

The most common qualification for major R&D professionals is Chemical Sciences (31.7 percent). It follows Pharmacy (15.9 percent), Pharmacology (12.0 percent), Biology (9.7 percent) and Chemical Biology (8.2 percent).

Local companies rely more intensively on professionals with a Chemical Sciences background (39.2 percent) as opposed to non-Chinese (16.1 percent).

Non-Chinese organizations source less professionals coming from universities in Shanghai and Jiangsu than their Chinese peers:  31.5 percent and 37.6 percent respectively, and focus more intensively in Beijing (15.5 percent, in contrast with the 6.0 percent of Chinese) and professionals with overseas studies (11.1 percent, vs. 1.6 percent for Chinese)

Another interesting insight comes when comparing where R&D professionals studied and their current location, with Shanghai and Beijing being net importers of university graduates. Only 28 percent of the professionals in Shanghai have studied there – the rest come mostly from neighboring provinces Jiangsu (15.5 percent) and Zhejiang (3.3 percent). When it comes to Beijing, 33.2 percent of the professionals have studied there, followed by Liaoning (10.0 percent), Tianjin (4.5 percent) and Hebei (4.2 percent).


Direct HR is a Top 10 China-focused recruitment firm servicing over 500 foreign and Chinese clients through offices in Shanghai, Beijing, Shenzhen and Ningbo. Direct HR specializes in the follow practicing areas: Engineering and Operations, Sales and Marketing, Finance and Accounting and Human Resources.

For further information, visit or contact 

Related Reading

Human Resources and Payroll in China 2015
This edition of Human Resources and Payroll in China, updated for 2015, provides a firm understanding of China’s laws and regulations related to human resources and payroll management – essential information for foreign investors looking to establish or already running a foreign-invested entity in China, local managers, and HR professionals needing to explain complex points of China’s labor policies.

Employing Foreign Nationals in China
In this issue of China Briefing, we have set out to produce a guide to employing foreign nationals in China, from the initial step of applying for work visas, to more advanced subjects such as determining IIT liability and optimizing employee income packages for tax efficiency. Lastly, recognizing that few foreigners immigrate to China on a permanent basis, we provide an overview of methods for remitting RMB abroad.

Adapting Your China WFOE to Service China’s Consumers
In this issue of China Briefing Magazine, we look at the challenges posed to manufacturers amidst China’s rising labor costs and stricter environmental regulations. Manufacturing WFOEs in China should adapt by expanding their business scope to include distribution and determine suitable supply chain solutions. In this regard, we will take a look at the opportunities in China’s domestic consumer market and forecast the sectors that are set to boom in the coming years.

China Market Watch: Exploring China’s Booming E-commerce and High Technology Manufacturing Industries

Posted on by

market watch-03

China Launches International Payment System to Boost E-commerce Industry

China’s Central Bank has recently launched the new China International Payment System (CIPS) in Shanghai, which will provide capital settlement and clearing services for cross-border RMB transactions affecting financial institutions domestically and abroad. The new CIPS was implemented in a move to facilitate trade clearing services for cross-border RMB transactions and improve clearing efficiency for direct participants in the RMB market. The new system is expected to lower transaction costs, reduce the processing times, and thus ease pressures on both local and international e-commerce platforms

China’s domestic payments system only supports Chinese characters, making it difficult for overseas financial institutions to directly clear RMB transactions with their Chinese counterparts. Previously, cross-border clearing of RMB funds had to be transacted either through one of the offshore RMB clearing banks in places such as Hong Kong, Singapore and London, or with the help of a corresponding bank on the Chinese mainland. 

Continue reading…

China Plus One – Where Foreign Investors Are Really Heading in Asia

Posted on by

CDE Op-Ed Commentary

Dezan Shira & Associates have just completed their 2015 annual meetings, this year held in Shanghai. Two days were given over to market analysis of foreign direct investment in the Asian region. Although 2015 represented a fairly tough year for foreign investment in China, several interesting trends have emerged, not least surrounding the so-called “China Plus One” strategy, which loosely describes the investment trends of foreign investors in China adding capacity in other, non-China Asian markets.

The practice researched the alternative Asia locations of some 1,500 of its larger China based clients, whose original investment base is typically the United States or Europe. The survey produced some unexpected results: 

Foreign Investors in China – The Most Popular Secondary Investments 

Hong Kong: 17.4%
India: 15.5%
Singapore: 12.7%
Malaysia: 6.8%
Thailand: 5.6%
Vietnam: 5.2%
Indonesia: 4.8%
Philippines: 3.8%
Cambodia: 1.3%

Continue reading…

China Outbound: Renewable Energy Investment in ASEAN Countries and New Regional Dynamics

Posted on by

Our Latest Round-Up of Business News Affecting China-Based Businesses Investing in Asia

In this edition of China Outbound, we look at the new economic and business environment of India and ASEAN countries, the tax and other incentives provided to companies seeking to invest in renewable energy industry in Singapore, as well as examine those of other countries within ASEAN. Then we discuss the stronger economic and political relationship between India and ASEAN countries. Lastly, we take a closer look at Vietnam’s seafood market (including both aquaculture and open ocean fishing) and India’s import-export landscape. 

Continue reading…

Living to Fight Another Day: Putting a Chinese Company in “Dormancy”

Posted on by

By Dezan Shira & Associates
Editor: Nathan Wakelin-King

What happens when a company enters the China market, fails in its initial efforts, but plans to come back later and try again?

Even if the product is identical, business success in China often requires differing strategies to what was successful in the Western world. A company may decide to halt its China operations, reassess its business strategy and management processes, and try again a few years later with a smarter strategy and/or more resources.

Putting a company in dormancy essentially means putting it in limbo – no income, minimal payments, shorter and therefore simpler tax audits – but crucially, the company is still registered, and can be revived by investors when required. This avoids the costly process of shutting down and reregistering.

The idea of corporate dormancy as an official legal status is not accepted in China. However, a company can achieve a quasi- dormant status: that is to say, maintaining a company legally registered in China for the minimum possible ongoing costs, ready for a future foray into China.

Continue reading…

China’s Annual Audit and Compliance Requirements

Posted on by

China Audit illustrationBy Dezan Shira & Associates
Editor: Steven Elsinga

According to PRC Company Law and other relevant regulations, all Foreign Invested Enterprises (FIEs) in China, including Wholly Foreign Owned Enterprises (WFOEs), Joint Ventures (JVs), Foreign Invested Commercial Companies (FICEs), and Representative Offices (ROs), are required to comply with the statutory annual audit and other compliance processes.

What are the key areas in an annual audit?

For JVs, WFOEs and FICEs, accounts related to purchases and sales are usually the most vulnerable areas in an annual audit, and so more time would typically be spent reviewing these accounts and ensuring that the accounting data is genuine and accurate. This is done by comparing the transactions with the corresponding contracts, invoices, orders, and inventory changes.

In addition, it is quite common for FIEs new to China to conduct most of their transactions with affiliated companies overseas. For example, they would import from their foreign parent company and either sell the products domestically, or export products purchased from China to their overseas affiliates. These transactions can raise issues in transfer pricing and bring the foreign company into non-compliance with the Chinese tax bureau.

For ROs, because daily business operations are relatively simple compared to other types of FIEs, more attention will be paid on expense accounts and  financial statements.

Continue reading…

The Nansha New Area Explained – Guangdong Free Trade Zone

Posted on by

Nansha new areaBy Omar Khan
International Business Advisory
Dezan Shira & Associates

Found at the central divergence of the Pearl River Delta, the Nansha New Area is one of three pre-existing development zones that came together to form the current Guangdong Free Trade Zone. With various export shipping routes and financial hub Hong Kong within the vicinity, it is worthwhile exploring the various facets of the Nansha New Area.

In this article, we look at some of the features outlining this development zone including a basic overview, major services, and finally, the objectives and mandates that the Nansha New Area intends to accomplish. Not only does this area have great potential to serve businesses within its proximity, but also has future potential to render itself a focal point of the 21st Century Maritime Silk Road.


Only 38 and 41 nautical miles away from Hong Kong and Macau, respectively, the Nansha New Area is positioned to be Guangzhou’s (and Guangdong’s) main gateway to sea-based trade. A vital transportation hub linking the above locations enables it to connect the PRD region as a whole. The actual Nansha area has a resident population of 720,000 within its 803 square kilometer space, with 60 square kilometers a part of the Guangdong Free Trade Zone. Nansha developed well in 2014 – area-wide GDP exceeded RMB 100 billion; industrial output value above designated scale reached RMB 270.6 billion, and the industrial output value of 50 key industrial enterprises grew by 14.53 percent.

Continue reading…

China Regulatory Brief: Catalogue of Codes on Tax Reduction & Exemption Policies

Posted on by
Catalogue of Codes of the Tax Reduction & Exemption Policies

On October 29, the State Administration of Taxation issued the Catalogue of Tax Reduction and Exemption Policy Codes. The Catalogue approaches clauses on central level tax reduction and exemption policies, current to the date of issue, including provisions on tax laws and regulations, and tax reduction & exemption policies which are either developed by the State Council or issued by central departments with the consent of the State Council’s authority. Policies developed and issued by the local authorities are pertinent to their respective regions, and are not covered in the Catalogue; corresponding policy codes and methods of issuance shall be otherwise determined by local taxation authorities.

Continue reading…

Scroll to top